Showing results 48 to 67 of 102
< previous
next >
| Issue Date | Title | Author(s) |
| 2020-01 | Microbial determinants of arthritis. | Shukla, SD; Shastri, MD; Jha, NK; Dua, K |
| 2022 | Microbiome in Idiopathic Pulmonary Fibrosis | Pathak, S; Mishra, A; Gupta, G; Raizaday, A; Singh, SK; Kumar, P; Singh, SK; Jha, NK; Chellappan, DK; Dua, K |
| 2021-12 | Microfluidic chips: recent advances, critical strategies in design, applications and future perspectives | Pattanayak, P; Singh, SK; Gulati, M; Vishwas, S; Kapoor, B; Chellappan, DK; Anand, K; Gupta, G; Jha, NK; Gupta, PK; Prasher, P; Dua, K; Dureja, H; Kumar, D; Kumar, V |
| 2021-07 | Middle East Respiratory Syndrome (MERS) Virus—Pathophysiological Axis and the Current Treatment Strategies | Alnuqaydan, AM; Almutary, AG; Sukamaran, A; Yang, BTW; Lee, XT; Lim, WX; Ng, YM; Ibrahim, R; Darmarajan, T; Nanjappan, S; Chellian, J; Candasamy, M; Madheswaran, T; Sharma, A; Dureja, H; Prasher, P; Verma, N; Kumar, D; Palaniveloo, K; Bisht, D; Gupta, G; Madan, JR; Singh, SK; Jha, NK; Dua, K; Chellappan, DK |
| - | Mitigating inflammation using advanced drug delivery by targeting TNF-α in lung diseases | Das, SS; Singh, SK; Verma, PRP; Jha, NK; Gupta, PK; Dua, K |
| - | Mitochondrial dysfunctions associated with chronic respiratory diseases and their targeted therapies: an update | Chellappan, DK; Dharwal, V; Paudel, KR; Jha, NK; MacLoughlin, R; Oliver, BG; M Hansbro, P; Dua, K |
| 2022-03 | Molecular mechanisms of developmental pathways in neurological disorders: a pharmacological and therapeutic review | Jha, NK; Chen, W-C; Kumar, S; Dubey, R; Tsai, L-W; Kar, R; Jha, SK; Gupta, PK; Sharma, A; Gundamaraju, R; Pant, K; Mani, S; Singh, SK; Maccioni, RB; Datta, T; Singh, SK; Gupta, G; Prasher, P; Dua, K; Dey, A; Sharma, C; Mughal, YH; Ruokolainen, J; Kesari, KK; Ojha, S |
| 2022-10-22 | Multifaceted role of synbiotics as nutraceuticals, therapeutics and carrier for drug delivery. | Khursheed, R; Gulati, M; Wadhwa, S; Vishwas, S; Sharma, DS; Corrie, L; Alam, A; Alnasser, SM; Aba Alkhayl, FF; Parveen, Z; Nammi, S; Chellappan, DK; Gupta, G; Zacconi, F; Steel, A; Adams, J; Jha, NK; Dua, K; Singh, SK |
| 2022-08-03 | Nanoparticulate drugs and vaccines: Breakthroughs and bottlenecks of repurposing in breast cancer. | Kumbhar, P; Kole, K; Khadake, V; Marale, P; Manjappa, A; Nadaf, S; Jadhav, R; Patil, A; Singh, SK; Dua, K; Jha, NK; Disouza, J; Patravale, V |
| 2022-12-31 | Nanotechnology-based drug delivery for the treatment of CNS disorders | Mittal, KR; Pharasi, N; Sarna, B; Singh, M; Rachana,; Haider, S; Singh, SK; Dua, K; Jha, SK; Dey, A; Ojha, S; Mani, S; Jha, NK |
| 2021-10 | Nanotechnology-based therapeutic formulations in the battle against animal coronaviruses: an update | Krishnan, S; Thirunavukarasu, A; Jha, NK; Gahtori, R; Roy, AS; Dholpuria, S; Kesari, KK; Singh, SK; Dua, K; Gupta, PK |
| 2004-01 | A novel Adaptive Fuzzy Logic Controller (A-FLC) to reduce retransmission and service roundtrip time for logical TCP channels over the Internet | Lin, WW; Wong, AK; Dillon, TS; Yang, L; Guo, M; Gao, GR; Jha, NK |
| - | Novel Nanostructured Lipid Carriers Co-Loaded with Mesalamine and Curcumin: Formulation, Optimization and In Vitro Evaluation | Awasthi, A; Kumar, B; Gulati, M; Vishwas, S; Corrie, L; Kaur, J; Khursheed, R; Muhammed, RA; Kala, D; Porwal, O; Babu, MR; Chaitanya, MVNL; Kumar, A; Pandey, NK; Dureja, H; Chellappan, DK; Jha, NK; Gupta, G; Prasher, P; Kumar, D; Dua, K; Singh, SK |
| 2022-02 | Nuclear factor-kappa B (NF-κB) inhibition as a therapeutic target for plant nutraceuticals in mitigating inflammatory lung diseases | Alharbi, KS; Afzal, O; almalki, WH; Kazmi, I; Javed Shaikh, MA; Thangavelu, L; Gulati, M; Singh, SK; Jha, NK; Gupta, PK; Chellappan, DK; Oliver, BG; Dua, K; Gupta, G |
| 2021-06 | Nuclear factor-kappa B and its role in inflammatory lung disease | Alharbi, KS; Fuloria, NK; Fuloria, S; Rahman, SB; Al-Malki, WH; Javed Shaikh, MA; Thangavelu, L; Singh, SK; Rama Raju, VS; Jha, NK; Chellappan, DK; Dua, K; Gupta, G |
| 2022-10-14 | Nutraceuticals and COVID-19: A mechanistic approach toward attenuating the disease complications. | Paudel, KR; Patel, V; Vishwas, S; Gupta, S; Sharma, S; Chan, Y; Jha, NK; Shrestha, J; Imran, M; Panth, N; Shukla, SD; Jha, SK; Devkota, HP; Warkiani, ME; Singh, SK; Ali, MK; Gupta, G; Chellappan, DK; Hansbro, PM; Dua, K |
| - | Nutraceuticals and mitochondrial oxidative stress: bridging the gap in the management of bronchial asthma | Allam, VSRR; Paudel, KR; Gupta, G; Singh, SK; Vishwas, S; Gulati, M; Gupta, S; Chaitanya, MVNL; Jha, NK; Gupta, PK; Patel, VK; Liu, G; Kamal, MA; Hansbro, PM; Oliver, BGG; Chellappan, DK; Dua, K |
| - | Nutraceuticals: unlocking newer paradigms in the mitigation of inflammatory lung diseases | Chan, Y; Raju Allam, VSR; Paudel, KR; Singh, SK; Gulati, M; Dhanasekaran, M; Gupta, PK; Jha, NK; Devkota, HP; Gupta, G; Hansbro, PM; Oliver, BGG; Chellappan, DK; Dua, K |
| 2022-01-01 | Occurrence and distribution of perfluoroalkyl acids in rivers: Impact and risk assessment | Verma, N; Rani, L; Rachmalla, M; Dua, K; Jha, NK |
| 2022-01-01 | Optimization Studies on Imatinib Mesylate Loaded Nanoliposomes Using Box-Behnken Design | Dahiya, M; Awasthi, R; Gupta, G; Singh, SK; Gulati, M; Jha, NK; Jha, SK; Sharma, A; Prasher, P; Anand, K; Chellappan, DK; Dua, K; Dureja, H |
